| The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: a systematic review DS Mathai, MJ Meyer, EA Storch, TR Kosten Journal of Affective Disorders 264, 123-129, 2020 | 86 | 2020 |
| Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: Results from a prospective, longitudinal survey AGR SM Nayak, H Jackson, ND Sepeda, DS Mathai, S So, A Yaffe, H Zaki, TJ ... Frontiers in Psychiatry 14, 2023 | 43 | 2023 |
| Toward synergies of ketamine and psychotherapy DS Mathai, V Mora, A Garcia-Romeu Frontiers in Psychology 13, 868103, 2022 | 36 | 2022 |
| Reconsidering “dissociation” as a predictor of antidepressant efficacy for esketamine DS Mathai, SM Nayak, DB Yaden, A Garcia-Romeu Psychopharmacology, 2023 | 29 | 2023 |
| Brief, parent-led, transdiagnostic cognitive-behavioral teletherapy for youth with emotional problems related to the COVID-19 pandemic AG Guzick, AW Leong, EM Dickinson, SC Schneider, K Zopatti, J Manis, ... Journal of affective disorders 301, 130-137, 2022 | 20 | 2022 |
| Deep transcranial magnetic stimulation for obsessive compulsive disorder AG McCathern, DS Mathai, RY Cho, WK Goodman, EA Storch Expert review of neurotherapeutics 20 (10), 1029-1036, 2020 | 19 | 2020 |
| Mapping consent practices for outpatient psychiatric use of ketamine DS Mathai, SM Lee, V Mora, KC O'Donnell, A Garcia-Romeu, EA Storch Journal of Affective Disorders 312, 113–121, 2022 | 12 | 2022 |
| Parental attitudes toward use of ketamine in adolescent mood disorders and suicidality DS Mathai, AG McCathern, AG Guzick, SC Schneider, S Weinzimmer, ... JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY 31 (8), 553-561, 2021 | 11 | 2021 |
| Guanfacine attenuates adverse effects of dronabinol (THC) on working memory in adolescent-onset heavy cannabis users: a pilot study DS Mathai, M Holst, C Rodgman, CN Haile, J Keller, MZ Hussain, ... The Journal of Neuropsychiatry and Clinical Neurosciences 30 (1), 66-76, 2018 | 10 | 2018 |
| Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeys CD Verrico, DS Mathai, H Gu, AR Sampson, DA Lewis Journal of Psychopharmacology 34 (2), 211-220, 2020 | 8 | 2020 |
| Paradoxical increase in synthetic cannabinoid emergency-related presentations after a citywide ban: Lessons from Houston, Texas DS Mathai, M Gordon, P Muchmore, A Matorin, A Shah, N Moukaddam Bulletin of the Menninger Clinic 80 (4), 357, 2016 | 6 | 2016 |
| At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data DS Mathai, TD Hull, L Vando, M Malgaroli Journal of affective disorders 361, 198-208, 2024 | 5 | 2024 |
| Double-blind comparison of the two hallucinogens dextromethorphan and psilocybin: experience-dependent and enduring psychological effects in healthy volunteers DS Mathai, S Hilbert, ND Sepeda, JC Strickland, RR Griffiths, ... Psychedelic Medicine, 2023 | 5 | 2023 |
| Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among US healthcare professionals E Wang, DS Mathai, N Gukasyan, S Nayak, A Garcia-Romeu Scientific reports 14 (1), 28022, 2024 | 4 | 2024 |
| The conundrum of therapeutic intoxication DS Mathai, DB Yaden, KC O’Donnell The British Journal of Psychiatry 221 (2), 496—497, 2022 | 4 | 2022 |
| A qualitative inquiry of parents’ observations of their children’s mental health needs during the COVID-19 pandemic AM Barth, AC Meinert, KL Zopatti, DS Mathai, AW Leong, EM Dickinson, ... Children's Health Care 51 (2), 213-234, 2022 | 4 | 2022 |
| Ketamine DS Mathai, S Mathew The American Psychiatric Publishing Textbook of Psychopharmacology, 2017 | 4 | 2017 |
| Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin Use DS Mathai, R DR, N SM, S ND, L A, J MW, L MX, J H, Garcia-Romeu A Journal of Psychoactive Drugs, 2025 | 3 | 2025 |
| Use of guanfacine for cannabis use disorder and related symptomology M Holst, DS Mathai, MM Patel, C Rodgman, J Keller, MZ Hussain, ... The American journal on addictions 28 (6), 455-464, 2019 | 3 | 2019 |
| Learning how to make use of dissociative therapies DS Mathai International Review of Psychiatry, 1-13, 2024 | 2 | 2024 |